Acadia Healthcare Company, Inc.
ACHC Healthcare Medical Care Facilities
Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 63.6%, free cash flow grew 856.5% and total debt rose 6.49%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow ACHC
Acadia Healthcare Company, Inc. (ACHC) EV/Sales
As of 16 October 2026, Acadia Healthcare Company, Inc. (ACHC) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 1.0× (January 2026) to 5.9× (June 2015); the current reading is higher than 12% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | (36.90%) |
| FY2024 | 1.7× | (38.97%) |
| FY2023 | 2.9× | (13.00%) |
| FY2022 | 3.3× | 12.87% |
| FY2021 | 2.9× | (14.90%) |
| FY2020 | 3.4× | 15.51% |
| FY2019 | 3.0× | 4.92% |
| FY2018 | 2.8× | 31.25% |
| FY2017 | 2.2× | 0.13% |
| FY2016 | 2.2× | (40.42%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | 9.90% |
| Mar 2026 | 1.3× | 20.64% |
| Dec 2025 | 1.1× | (18.68%) |
| Sep 2025 | 1.4× | 4.65% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ASTH Astrana Health, Inc. compare | 0.6× |
| MD Pediatrix Medical Group, Inc. compare | 1.2× |
| ADUS Addus HomeCare Corporation compare | 1.4× |
| ACHC Acadia Healthcare Company, Inc. | 1.5× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.6× |
| SGRY Surgery Partners, Inc. compare | 1.6× |
| GRDN Guardian Pharmacy Services, Inc. compare | 1.7× |
| BKD Brookdale Senior Living Inc. compare | 2.1× |
| NHC National HealthCare Corporation compare | 2.3× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)